From Yahoo Finance: 2025-06-13 14:02:00

Travere Therapeutics, Inc. (NASDAQ: TVTX) named one of the 10 Best Growth Stocks Under $100 to Buy Now by HC Wainwright & Co., with a price target of $30, presenting a potential 100% upside. The company plans to showcase FILSPARI’s impact in rare kidney disease at the International Podocyte Conference in Germany, highlighting reductions in biomarkers. With FILSPARI net sales up 182% year-over-year and approval in Europe and the UK, analysts are optimistic about Travere Therapeutics’ future. The California-based biopharmaceutical giant focuses on developing therapies for rare kidney and metabolic diseases. While TVTX shows promise, some AI stocks may offer greater potential.



Read more at Yahoo Finance: HC Wainwright Starts Travere Therapeutics, Inc. (TVTX) at Buy on FILSPARI Breakthroughs